Instructions to authors 2010

The European Journal of Dermatology publishes original papers and reviews pertinent to skin diseases and the normal and abnormal functions of the skin.

SUBMISSION IS ONLINE at http://libbey.fontismedia.com/ejd/

Editor-in-chief 

Dr Jean-François NICOLAS (France)

E-mail: jenny.messenger@chu-lyon.fr

Co-editors 

Dr Michael HERTL (Germany)

E-mail: EJD-Marburg@med.uni-marburg.de

Dr Andrea CAVANI (Italy)

E-mail: cavani@idi.it

Dr Ana GIMENEZ-ARNAU (Spain)

E-mail : 22505aga@comb.es

Dr Jean KANITAKIS

E-mail : jean.kanitakis@univ-lyon1.fr

Submission. Submission of an article is understood to imply that the article is original and unpublished and not being considered for publication elsewhere. The responsible author must ensure that the article has been seen and approved by all the other authors. All articles are subject to peer review by one or more referees and authors must propose 3 potential reviewers

Copyright. Authors of papers accepted for publication grant John Libbey Eurotext  an exclusive licence to publish, in return for which they can reuse their papers in their future printed work without first requiring permission from the publisher of the journal. Authors may archive this version of the manuscript in their institution's repositories and, if they wish, on their personal websites. Authors should cite the publication reference on any deposited version, and provide a link from it to the URL of the published article on the journal's website

.

Ethics. When reporting experiments on human and animal subjects, authors must indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human/animal experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as amended in 1983. If in doubt, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Clinical Trial Registration. The European Journal of Dermatology subscribes to the standards set forth by the International Committee of Medical Journal Editors in the Lancet (364:911-912, 2004), requiring that all trials that started enrolling participants after July 1, 2005 must be registered in a suitable publicly accessible register in order to be considered for publication in the Journal.     Suggested registers include www.clinicaltrials.gov, www.controlledtrials.com and www.nottingham.ac.uk/~muzd/about/ongo

Organisation of manuscripts. Every part of the manuscript should be numbered, beginning with the title page. Standard manuscripts should be: title page, abstract, introduction, materials and methods, results, discussion, acknowledgements, references, tables, legends for figures.

The Title page should contain (1) the full title, (2) a short title (3) full name(s) of the author(s), (4) complete postal address(es) of the affiliation(s) of the author(s), indicating the country in which the work was done, (5) an e-mail address to which proofs and reprint requests will be sent, plus telephone and fax numbers (6) the total number of words, figures, tables and references.

The Abstract should consist of no more than 200 words. Please provide about six key words, in alphabetical order, at the end of the abstract.

Materials and Methods should clearly and concisely describe all compounds and methods used. A brief note on the statistical methods used to evaluate the results should also be included. The briefest form should always be chosen for all data presented.

Acknowledgements. In this section the authors must declare:

-Financial support from the pharmaceutical industry or any other source. Grants and research contracts must indicate the name of the person or unit which received aid. A declaration must be made, if there has been no financial support, write NONE.

-Conflict of Interest. It is the responsibility of the corresponding author to ensure that any conflict of interest of any of the authors is disclosed. A declaration must be made, if there is no conflict of interest, write NONE.

References should be numbered consecutively as they appear in the text. References concerning unpublished data and ‘personal communications’ should be cited parenthetically within the text. Abbreviate journal names according to the listing in Index Medicus. Examples:

1. Yagi H, Tokura Y, Furukawa F, Takigawa M. Drug eruption caused by terfenadine. Eur J Dermatol 1996; 6: 81-2

2. Bork K. Cutaneous side effects of drugs. Philadelphia: W.B. Saunders, 1988: 133-47

3. Bleehen SS, Ebling FJG, Chanpion RH. Disorders of skin colour. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of Dermatology. 5th ed. Oxford: Blackwell Scientific Publications, 1992: 1561-2

Figures and diagrams should be referred to in the text as “Fig.” and be given arabic numbers. The magnification should be indicated directly on the figure using a bar and including the corresponding measurement in the legend. The graphic files must be saved as .JPEG.

All type within the figures should be at least size 9, using the following fonts: Helvetica, Arial, Times, Courrier, Symbol Line art should have a resolution of approximately 1 000 dpi.

Half-tone graphics (photographs or graphics with shades of grey) should have a resolution of 300 dpi. A figure that is a combination of both a half-tone and line art must have a resolution of at least 500 dpi.

Patients should have their identity concealed or should give written consent to publication. All figures and diagrams must be accompanied by a legend.

In the event that some of the illustrations are owned by third parties, the author must obtain the necessary permissions from the latter to include the illustrations in the article and the distribution thereof in this form. The manuscript must be accompanied by written permission for publication.

Tables should be drawn in black ink on a white background. Lines should be of sufficient thickness to withstand reduction. There should be as few tables as possible and these should include essential data only.

Units, symbols, abbreviations. Measurements should be in metric units (metre, kilogramme, litre) or their decimal multiples. Temperature should be given in °C. Abbreviations should be used sparingly and always given in full at the first mention.

Proof corrections are limited to typographical errors. One set of page proofs will be sent to the corresponding author who should return the corrected proofs within two days of receipt. The copyright form will accompany the proofs and must be returned with the corrected proofs. Following publication, a .pdf copy of the article will be sent to the corresponding author for personal use only.

Case reports will normally only considered for publication as items of correspondence and should therefore conform to the Instructions to authors for correspondence.

Correspondence includes brief clinical and investigative reports and letters concerning articles previously published in the EJD. Correspondence MUST be limited to a maximum of 600 words plus one figure/table (the figure can be a mounted one) and six references. There is no abstract / keywords. All correspondence is subject to possible editing/abridgement.

Announcements. Brief announcements of scientific meetings will be published at the discretion of the Editor, if space permits. Announcements must reach the editorial office at least 10 weeks before the publication date.

Page charges All corresponding authors will be asked to pay page charges of 150 euros or 250 US$ for accepted articles. The authors of invited articles will not be required to pay page charges.  Please note, there is no processing fee and no charge for colour illustrations. An invoice will be sent by email to the corresponding author of accepted articles at the same time as the proofs and copyright transfer form.

<< Retour